BIO DESIGN LAB Trademark

Trademark Overview


On Wednesday, July 14, 2021, a trademark application was filed for BIO DESIGN LAB with the United States Patent and Trademark Office. The USPTO has given the BIO DESIGN LAB trademark a serial number of 79319092. The federal status of this trademark filing is REGISTERED as of Tuesday, August 16, 2022. This trademark is owned by BioDesign Lab Co.,Ltd.. The BIO DESIGN LAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; vaccines against flu; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical agents affecting digestive organs; stem cells for veterinary purposes; antibodies for veterinary purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceut...
bio design lab

General Information


Serial Number79319092
Word MarkBIO DESIGN LAB
Filing DateWednesday, July 14, 2021
Status700 - REGISTERED
Status DateTuesday, August 16, 2022
Registration Number6816963
Registration DateTuesday, August 16, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Description of MarkThe mark consists of a circular circuit board with the outline of a seahorse in its center followed by the wording "BIO DESIGN LAB".
Goods and ServicesPharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; vaccines against flu; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; pharmaceutical agents affecting digestive organs; stem cells for veterinary purposes; antibodies for veterinary purposes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; allergy medications; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; medicines for the treatment of gastrointestinal diseases; nucleic acid sequences for medical and veterinary purposes; cells for medical purposes; reagents for use in medical genetic testing; diagnostic preparations for medical purposes; human immune globulin; pharmaceutical preparations for the treatment of auto-immune diseases; stem cells for medical purposes; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for diagnosis; anti-viral agents
Disclaimer with Predetermined Text"BIO DESIGN LAB"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 3, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioDesign Lab Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameBioDesign Lab Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameBioDesign Lab Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Wednesday, December 21, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 29, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 29, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 16, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 16, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 16, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022REFUSAL PROCESSED BY IB
Thursday, April 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 18, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 18, 2022REFUSAL PROCESSED BY MPU
Wednesday, April 13, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 12, 2022NON-FINAL ACTION WRITTEN
Monday, April 4, 2022ASSIGNED TO EXAMINER
Friday, November 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 7, 2021APPLICATION FILING RECEIPT MAILED
Friday, September 3, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB